相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation
Tao Liu et al.
NUCLEIC ACIDS RESEARCH (2020)
Glutaminases as a Novel Target for SDHB-Associated Pheochromocytomas/Paragangliomas
Balazs Sarkadi et al.
CANCERS (2020)
Pyruvate anaplerosis is a mechanism of resistance to pharmacological glutaminase inhibition in triple-receptor negative breast cancer
Dean C. Singleton et al.
BMC CANCER (2020)
METTL3 Facilitates Oral Squamous Cell Carcinoma Tumorigenesis by Enhancing c-Myc Stability via YTHDF1-Mediated m6A Modification
Wei Zhao et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
Clinical Significance of Serum Glutamine Level in Patients with Colorectal Cancer
Hang Huong Ling et al.
NUTRIENTS (2019)
YTHDF1 Regulates Tumorigenicity and Cancer Stem Cell-Like Activity in Human Colorectal Carcinoma
Yang Bai et al.
FRONTIERS IN ONCOLOGY (2019)
c-Myc Overexpression Promotes Oral Cancer Cell Proliferation and Migration by Enhancing Glutaminase and Glutamine Synthetase Activity
Tao Wang et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2019)
GAC inhibitors with a 4-hydroxypiperidine spacer: Requirements for potency
Lee McDermott et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
YTHDF1 links hypoxia adaptation and non-small cell lung cancer progression
Yulin Shi et al.
NATURE COMMUNICATIONS (2019)
Functions of N6-methyladenosine and its role in cancer
Liuer He et al.
MOLECULAR CANCER (2019)
The Prognostic Value of m6A RNA Methylation Regulators in Colon Adenocarcinoma
Tao Liu et al.
MEDICAL SCIENCE MONITOR (2019)
N6-methyladenosine links RNA metabolism to cancer progression
Dongjun Dai et al.
CELL DEATH & DISEASE (2018)
Sirtuin5 contributes to colorectal carcinogenesis by enhancing glutaminolysis in a deglutarylation-dependent manner
Yun-Qian Wang et al.
NATURE COMMUNICATIONS (2018)
Oncogene c-Myc promotes epitranscriptome m6A reader YTHDF1 expression in colorectal cancer
Yujiro Nishizawa et al.
Oncotarget (2017)
Adjuvant Chemotherapy for Stage II and III Colon Cancer Following Complete Resection: A Cancer Care Ontario Systematic Review
B. M. Meyers et al.
CLINICAL ONCOLOGY (2017)
Glutamine Metabolism in Cancer: Understanding the Heterogeneity
Ahmad A. Cluntun et al.
TRENDS IN CANCER (2017)
Strong synergy with APR-246 and DNA-damaging drugs in primary cancer cells from patients with TP53 mutant High-Grade Serous ovarian cancer
Asa Fransson et al.
JOURNAL OF OVARIAN RESEARCH (2016)
Personalizing Colon Cancer Adjuvant Therapy: Selecting Optimal Treatments for Individual Patients
Rodrigo Dienstmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
The effect of glutamine intake on complications of colorectal and colon cancer treatment: A systematic review
Maryam Miraghajani et al.
Journal of Research in Medical Sciences (2015)
Cisplatin in cancer therapy: Molecular mechanisms of action
Shaloam Dasari et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Molecular mechanisms of cisplatin resistance
L. Galluzzi et al.
ONCOGENE (2012)
分享论文
